UGT enzyme activity can be assessed through various methods, including in vitro assays using liver microsomes or recombinant enzymes, and in vivo studies evaluating the pharmacokinetics of UGT substrates. Genetic testing can also be performed to identify specific UGT polymorphisms that may impact enzyme activity. These assessments are essential for understanding individual differences in drug metabolism and for optimizing therapeutic regimens.
